Accuracy of Venous Excess Ultrasound Score at Hospital Admission to Predict Acute Kidney Injury
Launched by CAIRO UNIVERSITY · Jun 18, 2025
Trial Information
Current as of July 22, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new ultrasound test called the venous excess ultrasound score, which doctors hope can help predict whether women with severe preeclampsia—a serious pregnancy condition—might develop acute kidney injury, a sudden loss of kidney function. The goal is to see if this ultrasound score can accurately identify those at risk when they first arrive at the hospital.
Women who have severe preeclampsia may be eligible to participate, as long as they do not have existing kidney problems, have not had a kidney transplant, and can undergo the ultrasound test properly. If you join the trial, you would have this special ultrasound done at hospital admission to help doctors assess your kidney health. This study is not yet recruiting participants, but it aims to improve care by finding better ways to spot kidney issues early in women with severe preeclampsia.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • preeclampsia with severe features
- Exclusion Criteria:
- • Patient refusal
- • Preexisting renal impairment (defined as baseline serum creatinine \> 1.3 mg/dl)
- • Inability to obtain adequate Doppler views
- • Renal transplantation
- • Previous need for renal replacement therapy
- • Known peripheral vascular disease
About Cairo University
Cairo University, a premier institution in Egypt, is dedicated to advancing medical research and education through innovative clinical trials. With a strong emphasis on improving healthcare outcomes, the university collaborates with various stakeholders to conduct rigorous scientific studies that address critical health challenges. Leveraging its extensive resources and expert faculty, Cairo University aims to contribute valuable insights to the medical community and enhance patient care both locally and globally. Through its commitment to ethical research practices and excellence, the university plays a pivotal role in shaping the future of healthcare in the region.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Cairo, Giza Governorate, Egypt
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported